Bieglmayer C - Search Results

1

Primary hyperparathyroidism as the leading symptom in a patient with a Y791F RET mutation.

Vierhapper H, Rondot S, Schulze E, Wagner L, Hanslik S, Niederle B, Bieglmayer C, Kaserer K, Baumgartner-Parzer S. Vierhapper H, et al. Among authors: bieglmayer c. Thyroid. 2005 Nov;15(11):1303-8. doi: 10.1089/thy.2005.15.1303. Thyroid. 2005. PMID: 16356097

2

Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders.

Vierhapper H, Niederle B, Bieglmayer C, Kaserer K, Baumgartner-Parzer S. Vierhapper H, et al. Among authors: bieglmayer c. Thyroid. 2005 Nov;15(11):1267-72. doi: 10.1089/thy.2005.15.1267. Thyroid. 2005. PMID: 16356091

3

Prevalence of C-cell hyperplasia in patients with normal basal and pentagastrin-stimulated calcitonin.

Scheuba C, Kaserer K, Kotzmann H, Bieglmayer C, Niederle B, Vierhapper H. Scheuba C, et al. Among authors: bieglmayer c. Thyroid. 2000 May;10(5):413-6. doi: 10.1089/thy.2000.10.413. Thyroid. 2000. PMID: 10884188

4

Frequency of RET proto-oncogene mutations in patients with normal and with moderately elevated pentagastrin-stimulated serum concentrations of calcitonin.

Vierhapper H, Bieglmayer C, Heinze G, Baumgartner-Parzer S. Vierhapper H, et al. Among authors: bieglmayer c. Thyroid. 2004 Aug;14(8):580-3. doi: 10.1089/1050725041692990. Thyroid. 2004. PMID: 15320968

5

The role of intraoperative quick PTH measurements in primary hyperparathyroidism.

Prager G, Riss P, Bieglmayer C, Niederle B. Prager G, et al. Among authors: bieglmayer c. Ann Ital Chir. 2003 Jul-Aug;74(4):395-9. Ann Ital Chir. 2003. PMID: 14971281

6

Sporadic hypercalcitoninemia: clinical and therapeutic consequences.

Scheuba C, Kaserer K, Moritz A, Drosten R, Vierhapper H, Bieglmayer C, Haas OA, Niederle B. Scheuba C, et al. Among authors: bieglmayer c. Endocr Relat Cancer. 2009 Mar;16(1):243-53. doi: 10.1677/ERC-08-0059. Epub 2008 Nov 5. Endocr Relat Cancer. 2009. PMID: 18987170

7

Routine measurement of plasma calcitonin in nodular thyroid diseases.

Vierhapper H, Raber W, Bieglmayer C, Kaserer K, Weinhäusl A, Niederle B. Vierhapper H, et al. Among authors: bieglmayer c. J Clin Endocrinol Metab. 1997 May;82(5):1589-93. doi: 10.1210/jcem.82.5.3949. J Clin Endocrinol Metab. 1997. PMID: 9141554

8

Normal serum concentrations of sex hormone binding-globulin in patients with hyperthyroidism due to subacute thyroiditis.

Vierhapper H, Bieglmayer C, Nowotny P, Waldhäusl W. Vierhapper H, et al. Among authors: bieglmayer c. Thyroid. 1998 Dec;8(12):1107-11. doi: 10.1089/thy.1998.8.1107. Thyroid. 1998. PMID: 9920365

9

Bone metabolism in patients with primary hyperparathyroidism before and after surgery.

Kerschan-Schindl K, Riss P, Krestan C, Rauner M, Bieglmayer C, Gleiss A, Fialka-Moser V, Niederle B, Pietschmann P. Kerschan-Schindl K, et al. Among authors: bieglmayer c. Horm Metab Res. 2012 Jun;44(6):476-81. doi: 10.1055/s-0032-1308998. Epub 2012 Apr 11. Horm Metab Res. 2012. PMID: 22495973 Clinical Trial.

10

The use of the pyridostigmine growth hormone-releasing hormone stimulation test to detect growth hormone deficiency in patients with pituitary adenomas.

Vierhapper H, Nardi A, Bieglmayer C. Vierhapper H, et al. Among authors: bieglmayer c. Metabolism. 2002 Jan;51(1):34-7. doi: 10.1053/meta.2002.29010. Metabolism. 2002. PMID: 11782869

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters